However, there is an academic report presented that aberrant activation of the GIMAP enhancer contributed to regulate the transcription factor TAL1/SCL, which was one of the most prevalent oncogenes in T-cell acute lymphoblastic leukemia [25]. The gene discussed is TAL1; the disease is T-cell acute lymphoblastic leukemia.